Logo Image

Shorts

Steps Needed to Make Diabetic Peripheral Neuropathy Reversible
0:35
Steps Needed to Make Diabetic Peripheral Neuropathy Reversible
a month ago
by
Brian Callaghan, MD, MS
SLEEP 2026: Key Takeaways From New Hospital-Based Sleep Apnea Guidelines
0:57
SLEEP 2026: Key Takeaways From New Hospital-Based Sleep Apnea Guidelines
a month ago
by
Sunil Sharma, MD(+1 more)
SLEEP 2026: What Is a Common Sleep-Related Question?
1:04
SLEEP 2026: What Is a Common Sleep-Related Question?
a month ago
by
Beth Malow, MD, MS(+1 more)
ATMRD 2026: Overlooked Symptoms of Autonomic Dysfunction in PD
1:11
ATMRD 2026: Overlooked Symptoms of Autonomic Dysfunction in PD
a month ago
by
Louie Pasculli(+2 more)
SLEEP 2026: AASM Guideline for Treating Chronic Insomnia
1:09
SLEEP 2026: AASM Guideline for Treating Chronic Insomnia
a month ago
by
Salma Patel, MD(+1 more)
Biggest Misconceptions Regarding Immune-Mediated Small Fiber Neuropathy
0:35
Biggest Misconceptions Regarding Immune-Mediated Small Fiber Neuropathy
a month ago
by
Matthew Evans, BM, BCh, DPhil
Goals for Expanding Knowledge on Programmed Axon Death
0:25
Goals for Expanding Knowledge on Programmed Axon Death
a month ago
by
Michael Coleman, PhD
Improving Basic Science Objectives for Peripheral Nerve Disorders
0:20
Improving Basic Science Objectives for Peripheral Nerve Disorders
a month ago
by
Carla Taveggia, PhD
Confocal Corneal Microscopy as an Emerging Biomarker for Peripheral Nerve Disorders
0:20
Confocal Corneal Microscopy as an Emerging Biomarker for Peripheral Nerve Disorders
a month ago
by
Brett Morrison, MD, PhD
Addressing an Overlooked Gap in MS Clinical Trials
0:32
Addressing an Overlooked Gap in MS Clinical Trials
a month ago
by
Louie Pasculli(+1 more)
Key Areas of Neuropathy Research: Keeping and Optimizing Animal Models
0:20
Key Areas of Neuropathy Research: Keeping and Optimizing Animal Models
a month ago
by
Ahmet Hoke, MD, PhD
Underexplored, Emerging Biomarkers for ALS
0:48
Underexplored, Emerging Biomarkers for ALS
a month ago
by
Jinsy A. Andrews, MD, MSc
Exploring the Possibility of Treating ALS in the Prodromal Stage
0:56
Exploring the Possibility of Treating ALS in the Prodromal Stage
a month ago
by
Jinsy A. Andrews, MD, MSc
ATMRD 2026: Redefining Wellness in Parkinson Disease
1:04
ATMRD 2026: Redefining Wellness in Parkinson Disease
a month ago
by
Louie Pasculli(+1 more)
Emerging Retinal Biomarkers of Neurodegeneration
0:56
Emerging Retinal Biomarkers of Neurodegeneration
a month ago
by
Dimitra Skondra, MD, PhD
CMSC 2026: Key Highlights in Multiple Sclerosis Care
1:21
CMSC 2026: Key Highlights in Multiple Sclerosis Care
a month ago
by
Carrie Hersh, DO, MSc, FAAN(+1 more)
ATMRD 2026: The Future of Clinical Trials Is Closer to Home
0:47
ATMRD 2026: The Future of Clinical Trials Is Closer to Home
a month ago
by
David Shprecher, DO, MSci, FAAN(+1 more)
CMSC 2026: Aging and Treatment Strategies in MS
1:07
CMSC 2026: Aging and Treatment Strategies in MS
2 months ago
by
Amy Gutierrez, MD, FAAN(+1 more)
RECAP: Neurology News Network - June 6th
1:52
RECAP: Neurology News Network - June 6th
2 months ago
by
Louie Pasculli
ATMRD 2026 Session Spotlight: Experiencing Parkinson Speech Therapy Firsthand
1:34
ATMRD 2026 Session Spotlight: Experiencing Parkinson Speech Therapy Firsthand
2 months ago
by
Anissa Mitchell, LCSW(+1 more)
Call to Action: Why Clinicians Should Explore ISSCR's New Stem Cell Course
0:35
Call to Action: Why Clinicians Should Explore ISSCR's New Stem Cell Course
2 months ago
by
Claire Henchcliffe, MD, DPhil
How Stem Cells Differ From Levodopa
2:27
How Stem Cells Differ From Levodopa
2 months ago
by
Claire Henchcliffe, MD, DPhil
The Science Behind Cell Replacement
1:25
The Science Behind Cell Replacement
2 months ago
by
Roger A. Barker, MD, PhD
CMSC 2026: Cognitive Screening in Multiple Sclerosis
1:25
CMSC 2026: Cognitive Screening in Multiple Sclerosis
2 months ago
by
Elizabeth S. Gromisch, PhD(+1 more)
How to Counsel Patients on Emerging Stem Cell Treatments
1:27
How to Counsel Patients on Emerging Stem Cell Treatments
2 months ago
by
Claire Henchcliffe, MD, DPhil
The Case for Expanding MS Clinical Trial Eligibility
0:41
The Case for Expanding MS Clinical Trial Eligibility
2 months ago
by
Jacqueline Nicholas, MD, MPH(+1 more)
Overviewing ISSCR's New Course on Parkinson Disease and Stem Cell Medicine
0:46
Overviewing ISSCR's New Course on Parkinson Disease and Stem Cell Medicine
2 months ago
by
Roger A. Barker, MD, PhD
CMSC 2026: The Patient Journey of Living With MS
1:25
CMSC 2026: The Patient Journey of Living With MS
2 months ago
by
Jamie Lynn Sigler(+1 more)
Are MS Trial Categories Outdated?
0:51
Are MS Trial Categories Outdated?
2 months ago
by
Stephen Krieger, MD(+1 more)
CMSC 2026: Misconceptions on Stopping DMTs in Multiple Sclerosis
1:25
CMSC 2026: Misconceptions on Stopping DMTs in Multiple Sclerosis
2 months ago
by
John Corboy, MD(+1 more)